Investor presentation at a biotech conference
December 6, 2022
See the summary video from the investor biotech conference presentation
On December 6, 2022, Marcin Staniszewski, CEO of SDS Optic S.A., and Mateusz Sagan, Chief Operating and Business Development Manager, took part in a highly engaging event that brought together prominent figures from the Polish biotechnology sector. In addition to participating in discussion panels and networking during informal conversations, we had the opportunity to share more about the financing of our growth, the company's path to the Warsaw Stock Exchange (GPW), and the future development of the inPROBE® technology.
Our brand maintains a stable and attractive position in the market and has become a well-established part of the Polish biotechnology landscape. We are truly pleased to be able to share our experiences.
Source: SDS Optic S.A. | December 6, 2022